Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioUp is a private U.S. company commercializing a patented liposomal delivery technology designed to improve the bioavailability of nutrients and other active ingredients. The company, legally Bio-Up Mimetic Technologies, develops and licenses nature-inspired lipid vesicle formulations for applications spanning health and wellness, food and beverage, personal care, pet care, agriculture, and aquaculture. Its platform originated from pharmaceutical-style liposome science and has been applied to functional consumer products including heart-health beverages. BioUp appears to operate primarily as a platform and ingredient technology company rather than a traditional therapeutic drug developer, with revenue opportunities tied to branded products, partnerships, and technology licensing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioUp.